Table 2 Baseline characteristics of possible TBM and definite/probable TBM

Age^a (months)

24.5 (2–165)

36.5 (2–180)

Male (%)

18/28 (64 %)

38/72 (53 %)

Fever

28/28 (100 %)

71/72 (99 %)

Symptom duration^a (days)

16 (6–60)

19.5 (6–96)

Vomiting

20/28 (71 %)

56/72 (78 %)

Altered sensorium

6/28 (21 %)

36/72 (50 %)

Fits

9/28 (32 %)

30/72 (40 %)

Neck stiffness

17/28 (61 %)

58/72 (81 %)

Motor deficit

4/25 (16 %)

28/60 (47 %)

Cranial nerve palsy

9/28 (32 %)

18/72 (25 %)

HIV infection

1/28 (4 %)

3/72 (4 %)

HBV infection

2/28 (7 %)

3/72 (4 %)

Family TB history

7/28 (25 %)

19/72 (26 %)

Death

2/27 ^b (7 %)

13/69 (19 %) ^c

Permanent sequelae

2/25 (8 %)

25/56 (45 %)

CSF WCC^a (cells/uL)

144 (4–780)

150 (1–802)

CSF Lymph^a (cells/uL)

80 (40–100)

80 % (50–100)

CSF Protein^a (g/L)

0.8 (0.2–5)

1.3 (0.1–4.8)

CSF Lactate^a (mmol/L)

4.3 (1.4–8.8)

5.6 (1.21–19.2)

CSF: Blood Glucose ratio^a

0.30 (0.09–0.61)

0.25 (0.07–0.69)